Laura Rizzoli Selected Research

Sclerosis

1/2018

Acrodermatitis continua of Hallopeau successfully treated with secukinumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Rizzoli Research Topics

Disease

1	Tuberous Sclerosis (Bourneville's Disease) 03/2023
1	Neurocutaneous Syndromes (Phakomatoses) 03/2023
1	Angiofibroma 03/2023
1	Scabies (Sarcoptic Mange) 01/2022
1	Acrodermatitis (Gianotti Crosti Syndrome) 01/2018
1	Osteolysis 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Sclerosis 01/2018
1	Dermatitis 12/2011
1	Atopic Dermatitis (Atopic Eczema) 12/2011

Drug/Important Bio-Agent (IBA)

1	trans-sodium crocetinate (crocetin)IBA 03/2023
1	MTOR InhibitorsIBA 03/2023
1	Sirolimus (Rapamycin)FDA Link 03/2023
1	Permethrin (Ambush)FDA LinkGeneric 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	secukinumabIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Immunoglobulin A (IgA)IBA 12/2011

Therapy/Procedure

1	Therapeutics 01/2018
1	Balneology 12/2011